Boosting antibody developability through rational sequence optimization-Reference-Cited by-同舟云学术

Boosting antibody developability through rational sequence optimization

Published:2015-03-11 Issue:3 Volume:7 Page:505-515
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Seeliger Daniel,Schulz Patrick,Litzenburger Tobias,Spitz Julia,Hoerer Stefan,Blech Michaela,Enenkel Barbara,Studts Joey M,Garidel Patrick,Karow Anne R

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2015.1017695

Reference50 articles.

1. Antibodies to watch in 2014

2. Can the pharmaceutical industry reduce attrition rates?

3. Protein aggregation and bioprocessing

4. Process economics of industrial monoclonal antibody manufacture

5. Structure-based engineering of a monoclonal antibody for improved solubility

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing Robust Monoclonal Antibody Drug Products: Pitfalls of Simplistic Approaches for Stability Prediction;Journal of Pharmaceutical Sciences;2024-08

2. Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability;Communications Biology;2024-07-31

3. A systemic approach to identifying sequence frameworks that decrease mAb production in a transient Chinese hamster ovary cell expression system;Biotechnology Progress;2024-04-12

4. Structural modifications for the conversion of proteins and peptides into stable dried powder formulations: A review;Journal of Drug Delivery Science and Technology;2023-11

5. Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability;2023-10-30